BIOMAT Database Logo BIOMAT Database Logo

Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route. 1976

A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor

Influenza vaccinations were performed either by administration of a bivalent A2 + B vaccine, or by successive application of monovalent B and A2 vaccines. During an influenza epidemic caused by an A2 strain, the following observations could be made: a) the best efficiency (no influenza cases) was recorded in adults and aged persons (over 65 years) irrespective of the vaccination scheme; b) in schoolchildren the best results (no influenza cases) were obtained in the lot having received monovalent A2 vaccine, and in the lot vaccinated nasally with monovalent B vaccine and 14 days later with monovalent A vaccine.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
Immunogenicity of inactivated vaccines prepared with parainfluenza viruses type 1 and type 3, administered experimentally by nasal or oral route.
January 1998, Romanian journal of virology,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route.
January 1984, Virologie,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
[Influenza vaccination in children: Inactivated vaccines or live attenuated vaccines?]
March 2017, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine.
May 2024, BMC infectious diseases,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
[Comparative study of the immunogenicity in mice, of human influenza viruses inactivated by various procedures and administered subcutaneously or by nasal route].
February 1969, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
[Comparative studies on the vaccination of mice with inactivated influenza virus administered by the aerosol technique, by the intranasal or intramuscular route (author's transl)].
December 1979, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines.
April 2015, Vaccines,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
[Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
January 1972, Bollettino dell'Istituto sieroterapico milanese,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines.
January 2008, Archives of virology,
A Petrescu, and A Mihail, and A Popescu, and M Cojiţă, and I Sternberg, and N Steiner, and C Hondor
Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.
October 1969, American journal of epidemiology,
Copied contents to your clipboard!